Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2419 (LINC02419)

Target
LINC02419
Molecular classification
Other (Long non-coding RNA, specifically a long intergenic non-coding RNA/lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2419 (LINC02419) is a long non-coding RNA (specifically, a long intergenic non-coding RNA/lincRNA), meaning it is an RNA transcript longer than 200 nucleotides that does not encode a protein and does not overlap annotated protein-coding genes[1][3]. Like other lincRNAs, LINC02419 may be involved in regulating gene expression at the transcriptional and post-transcriptional levels, possibly by interacting with chromatin, modulating the activity of proteins, or stabilizing/degrading mRNA transcripts[3][5]. It has been identified as a component of diagnostic signatures able to discriminate tumors from normal samples, particularly in lung cancer datasets, suggesting its value as a biomarker for disease detection but not as a direct therapeutic target or receptor[2]. No interacting drugs or recognized therapeutic mechanisms are associated with LINC02419. **Note:** - LINC02419 is *not* a protein, receptor, enzyme, transporter, or typical direct therapeutic target[1][3]. - Its primary documented application is as a *potential biomarker* in cancer diagnostics (not therapy)[2]. - There is no indication of misspelling or error in the target designation, nor excessive or insufficient information for standard molecular target annotation.

Other names
LINC02419Long intergenic non-coding RNA 2419
02

Biological functions

Gene expression regulationChromatin remodelingPotential modulation of neighboring gene activity
03

Disease associations

Possible biomarker in cancer (supported as a diagnostic signature or classifier in lung cancer; also identified as one of several lncRNAs discriminating tumor from normal tissue in machine learning analyses)
04

Biomarkers

Possible diagnostic biomarker for lung cancer (part of a lncRNA signature discriminating between cancer and normal samples; proposed for blood-based diagnostics)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2419 (LINC02419).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2419 (LINC02419).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call